Fig. 1 · Structure

Documents & Downloads

Imipenem

Cat. No. A14942 CAS 64221-86-9
Imipenem is an intravenous betalactam antibiotic discovered by Merck scientists Burton Christensen, William Leanza, and Kenneth Wildonger in 1980.

In Stock

Publications for Imipenem

6 publications citing this product

  1. Isabelle Bonnet, .et al. , Microbiol Spectr, 2026, Apr 7;14(5):e03805-25 PMID: 41944630
  2. Rachel F. Rollo, .et al. , Microbiol Spectr, 2023, Jul-Aug; 11(4) PMID: 37289062
  3. Viktoria Lazar, .et al. , Nature, 2022, 610: 540-546 PMID: 36198788
  4. Hongwei Liu, .et al. , New Phytol, 2020, Oct 31 PMID: 33131088
  5. Pholwat S, .et al. , PLoS One, 2019, May 10;14(5):e0216747 PMID: 31075137
  6. Meikle V, .et al. , Antimicrob Agents Chemother, 2018, Nov 12. pii: AAC.01846-18 PMID: 30420480

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Bioactivity / Mechanism

Imipenem forms a covalent acyl-enzyme complex with Ser44 of isolated E. coli PBP5, as shown by a 1.50 Å crystal structure. Its extended side chain is weakly resolved, limiting conclusions about side-chain recognition in this soluble-protein model. [1]

In a separate 1.80 Å structure of E. coli AmpC β-lactamase, imipenem is covalently bound to Ser64 with its lactam carbonyl oriented away from the oxyanion hole. This geometry supports an enzyme-specific explanation for impaired deacylation; it does not establish universal β-lactamase stability. [2]

Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.

Imipenem Research Summary

This section summarizes 2 in vitro studies of Imipenem from 2 published references. In vitro models include isolated wild-type Escherichia coli AmpC β-lactamase crystals.

Imipenem In Vitro Studies

Covalent imipenem complex with E. coli PBP5

Biochemical assay · Soluble wild-type Escherichia coli penicillin-binding protein 5 crystals [1]

Electron density supports a covalent Ser44–imipenem acyl-enzyme linkage. The R2 side chain is weakly resolved. The soluble crystal construct may differ from membrane-associated PBP5.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
Diffraction resolution of the imipenem complexResolution 1.50 Å[1]
Acyl-enzyme formation at Ser44Structural observation Covalent linkage supported by electron density[1]

Literature-Reported Treatment Conditions

Treatment concentration
10 mM
Exposure duration
90 min
Method
Crystal soaking followed by X-ray diffraction. Table 1 supplies the imipenem-specific conditions; the generic 2–4 h methods range is not substituted.
Vehicle
Stabilizing solution with PEG 400 and Tris-HCl; glycerol cryoprotection (Materials and Methods).
Reported limits
Salt/hydrate, purity and lot not specified in the reviewed material. No biological replicate n is specified for this single reported crystal structure.
Methods and source locations

Compound reported in the paper: Imipenem; Compound label in the paper: imipenem

Applies to the parent imipenem molecule in this isolated-protein experiment; does not validate an Adooq lot or a specific salt/hydrate.

Results: Description of the three structures—Imipenem; Figure 2A and caption; Table 1, Imipenem column; Materials and Methods—Crystal Soaking; Discussion—Lack of electron density for β-lactam side chains

Diffraction resolution of the imipenem complex: X-ray crystallography; PDB 3MZF — Table 1, Imipenem column; Figure 2A caption

Acyl-enzyme formation at Ser44: Difference omit electron density with imipenem and Ser44 omitted; caption contour 2.8 sigma — Results—Imipenem; Figure 2A and caption

Covalent imipenem complex with wild-type AmpC

Biochemical assay · Isolated wild-type Escherichia coli AmpC β-lactamase crystals [2]

Imipenem is covalently attached to Ser64. Its lactam carbonyl points away from the oxyanion hole, supporting a structural explanation for impaired deacylation in this enzyme.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
Diffraction resolution of the AmpC–imipenem complexResolution 1.80 Å[2]
Orientation of the lactam carbonyl oxygen relative to its expected oxyanion-hole positionStructural displacement approximately 180°; 2.9 Å[2]

Literature-Reported Treatment Conditions

Treatment concentration
Saturated imipenem; molarity not reported
Exposure duration
40 min
Method
Crystal soaking followed by X-ray crystallography.
Vehicle
Crystallizing buffer; subsequent sucrose cryoprotection.
Reported limits
Imipenem supplier, salt/hydrate, purity and lot are not specified in the reviewed main text. Two molecules in the asymmetric unit are not two independent experiments.
Methods and source locations

Compound reported in the paper: Imipenem; Compound label in the paper: imipenem

Applies to the parent imipenem molecule in this isolated-protein experiment; does not validate an Adooq lot or a specific salt/hydrate.

Main text: crystallographic methods and paragraphs beginning The electron density and Imipenem appears; Figure 2A–B and Figure 3A; Tables 1–2

Diffraction resolution of the AmpC–imipenem complex: X-ray crystallography; PDB 1LL5 — Table 1; abstract; crystallographic methods

Orientation of the lactam carbonyl oxygen relative to its expected oxyanion-hole position: Reported structural comparison; approximate angle is author-reported, not estimated from the figure — Main text paragraph beginning The electron density; Figures 2–3

Specifications

Manufacturer Adooq Bioscience
CAS Number 64221-86-9
Formula C12H17N3O4S
Molecular Weight 299.34
SMILES
CC(C1C2CC(=C(N2C1=O)C(=O)O)SCCN=CN)O

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Imipenem Research References

  1. [1] George Nicola, Joshua Tomberg, R F Pratt, et al. Crystal structures of covalent complexes of β-lactam antibiotics with Escherichia coli penicillin-binding protein 5: toward an understanding of antibiotic specificity. Biochemistry (2010). PMID: 20726582 DOI: 10.1021/bi100879m Source material
  2. [2] Beth M Beadle, Brian K Shoichet. Structural basis for imipenem inhibition of class C beta-lactamases. Antimicrobial Agents and Chemotherapy (2002). PMID: 12435704 DOI: 10.1128/aac.46.12.3978-3980.2002 Source material

Publications

6 publications citing this product

  1. Isabelle Bonnet, .et al. , Microbiol Spectr, 2026, Apr 7;14(5):e03805-25 PMID: 41944630
  2. Rachel F. Rollo, .et al. , Microbiol Spectr, 2023, Jul-Aug; 11(4) PMID: 37289062
  3. Viktoria Lazar, .et al. , Nature, 2022, 610: 540-546 PMID: 36198788
  4. Hongwei Liu, .et al. , New Phytol, 2020, Oct 31 PMID: 33131088
  5. Pholwat S, .et al. , PLoS One, 2019, May 10;14(5):e0216747 PMID: 31075137
  6. Meikle V, .et al. , Antimicrob Agents Chemother, 2018, Nov 12. pii: AAC.01846-18 PMID: 30420480

Added to your cart

View Cart Checkout
Loading...